Mutation allele burden remains unchanged in chronic myelomonocytic leukaemia responding to hypomethylating agents
2016 · Nature Communications · 213 citations
https://doi.org/10.1038/ncomms10767
J
Jane Merlevede
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
35
Papers
706
Citations
8
h-index
7
i10-index
Jane Merlevede is an academic researcher from Université Paris Sciences et Lettres. The author has contributed to research in topics: Glioma Diagnosis and Treatment & RNA modifications and cancer & Acute Myeloid Leukemia Research. The author has an h-index of 8, co-authored 30 publications.
ORCID: 0009-0000-0192-756XPapers by this author
worksDECONbench: a benchmarking platform dedicated to deconvolution methods for tumor heterogeneity quantification
2021 · BMC Bioinformatics · 8 citations
https://doi.org/10.1186/s12859-021-04381-4
Additional file 1: of Transcriptomic and epigenetic profiling of â diffuse midline gliomas, H3 K27M-mutantâ discriminate two subgroups based on the type of histone H3 mutated and not supratentorial or infratentorial location
2018 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.7300874
Additional file 2: of Transcriptomic and epigenetic profiling of ‘diffuse midline gliomas, H3 K27M-mutant’ discriminate two subgroups based on the type of histone H3 mutated and not supratentorial or infratentorial location
2018 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.7300886
Additional file 4: of Transcriptomic and epigenetic profiling of â diffuse midline gliomas, H3 K27M-mutantâ discriminate two subgroups based on the type of histone H3 mutated and not supratentorial or infratentorial location
2018 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.7300913
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat